Relative frequency of inherited retinal dystrophies in Brazil

Author(s)

Motta, Fabiana Louise ^[1] ; Martin, Renan Paulo ^{[2, 3]} ; Filippelli-Silva, Rafael ^[2] ; Salles, Mariana Vallim ^[1] ; Ferraz Sallum, Juliana Maria ^{[1, 4]}

Affiliation

^[1] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo - Brazil

^[2] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo - Brazil

^[3] Johns Hopkins Med, Inst Med Genet, Baltimore, MD - USA

^[4] Inst Genet Ocular, Sao Paulo - Brazil

• Document type: Journal article
• Source: SCIENTIFIC REPORTS; v. 8, OCT 29 2018.
• Web of Science Citations: 0

Abstract

Among the Brazilian population, the frequency rates of inherited retinal dystrophies and their causative genes are underreported. To increase the knowledge about these dystrophies in our population, we retrospectively studied the medical records of 1,246 Brazilian patients with hereditary retinopathies during 20 years of specialized outpatient clinic care. Of these patients, 559 had undergone at least one genetic test. In this cohort, the most prevalent dystrophies were non-syndromic retinitis pigmentosa (35%), Stargardt disease (21%), Leber congenital amaurosis (9%), and syndromic inherited retinal dystrophies (12%). Most patients had never undergone genetic testing (55%), and among the individuals with molecular test results, 28.4% had negative or inconclusive results compared to 71.6% with a conclusive molecular diagnosis. ABCA4 was the most frequent disease-causing gene, accounting for 20% of the positive cases. Pathogenic variants also occurred frequently in the CEP290, USH2A, CRB1, RPGR, and CHM genes. The relative frequency rates of different inherited retinal dystrophies in Brazil are similar to those found globally. Although mutations in more than 250 genes lead to hereditary retinopathies, only 66 genes were responsible for 70% of the cases, which indicated that smaller and cheaper gene panels can be just as effective and provide more affordable solutions for implementation by the Brazilian public health system. (AU)

• FAPESP's process: 14/20965-3 - In silico study of genetic mutations causing hereditary angioedema
• Grantee: Renan Paulo Martin
• Support Opportunities: Scholarships in Brazil - Post-Doctoral